cbdMD Buys Twinlab
Deal to boost revenue by $30M

cbdMD is acquiring Twinlab supplement brands in a move that aims to boost its revenue. The acquisition is expected to result in a $30M revenue boost for cbdMD.
The deal is part of cbdMD's strategy to expand its portfolio and increase its revenue. By acquiring Twinlab supplement brands, cbdMD is looking to strengthen its position in the market.
## What the Acquisition Means The acquisition of Twinlab supplement brands by cbdMD is a significant move for the company. It is expected to bring in an additional $30M in revenue, which will help cbdMD to grow its business.
The acquisition is also a sign of cbdMD's commitment to expanding its portfolio and increasing its revenue. By acquiring established brands like Twinlab, cbdMD is looking to strengthen its position in the market and increase its competitiveness.
## Why it Matters The acquisition of Twinlab supplement brands by cbdMD matters because it shows the company's strategy to grow its business through acquisitions. The deal is expected to have a positive impact on cbdMD's revenue, and it will help the company to expand its portfolio and increase its market share.
The acquisition is also a sign of the growing demand for supplement brands, and it highlights the importance of having a strong portfolio in the market. As the demand for supplements continues to grow, companies like cbdMD are looking to expand their portfolios and increase their revenue through acquisitions.





